Subsequently, to determine whether CXCL16 expression levels were causally regulated by pyroptosis induction, we treated psoriasis-derived MDMs with the pyroptosis-specific inhibitor VX-765 for 48 h and quantified CXCL16 gene expression. Here, CXCL16 is linked to psoriasis.